CW-301 FIH Study of CAN016

NCT07664150 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Patients With Advanced Solid Tumors

Interventions

DRUG: CAN016
DRUG: CAN016

Sponsor

Canwell Biotech Limited